indiana fishing license
winner777
In conclusion, Guardiola's decision to step away from coaching other clubs or national teams serves as a poignant reminder of the sacrifices and challenges that come with success in the world of football. As he seeks solace and renewal, the footballing world will undoubtedly miss his presence on the touchline, but his legacy will endure as a testament to his unparalleled dedication and innovation in the sport.Maressa, a seasoned vocal coach with years of experience in the industry, has been working closely with Jack Harlow to help him develop his unique style and delivery. Her dedication to his growth as an artist has not gone unnoticed, with the rapper praising her professionalism and expertise in his post.
In a touching display of selflessness and compassion, a man recently passed away and chose to donate his organs to save the lives of others. As his family gathered to bid him farewell, they made a decision that truly tugged at the heartstrings of all who witnessed it.
NoneNEW YORK--(BUSINESS WIRE)--Dec 20, 2024-- Aptorum Group Limited (NASDAQ: APM) (“Aptorum Group” or the “Company”), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune and infectious diseases, today provided a business update and announced financial results for the six months ended June 30, 2024. “Our team and Yoov have spent considerable time and effort on the due diligence process, the negotiation of definitive terms, and the preparation of necessary transactional and listing documentation. However, current market conditions have introduced significant uncertainty regarding the availability of the required funding for the transaction. After careful consideration, our Board has determined that it is no longer in the best interests of our shareholders to proceed with this transaction. Despite this, we will continue to explore other business combination opportunities that we believe will enhance shareholder value,” stated Mr. Ian Huen, Chief Executive Officer and Executive Director of Aptorum Group Limited. Corporate Highlights On October 24, 2024, the Company and Yoov Group Holding Limited (“Yoov”) entered into a termination agreement and the anticipated reverse takeover transaction with Yoov was terminated. Financial Results for the Six Months Ended June 30, 2024 Aptorum Group reported a net loss of $2.7 million for the six months ended June 30, 2024 compared to $6.6 million for the same period in 2023. The decrease in net loss in the current period was driven by the decrease in operating expenses by $4.1 million due to the implementation of stringent budgetary control measures, as a result of the Company’s exclusive emphasis on the previous anticipated RTO. Research and development expenses were $2.0 million for the six months ended June 30, 2024 compared to $3.2 million for the same period in 2023. Before the Merger Agreement was terminated, we determined it was best to focus all of our attention and resources on completing the Merger and therefore paused the majority of our R&D activities during that time; following the termination of the Merger Agreement in the fourth quarter of fiscal 2024, we determined that searching for other business combination opportunities could maximize shareholder value, and our R&D activities remain suspended. General and administrative fees were $0.3 million for the six months ended June 30, 2024 compared to $1.3 million for the same period in 2023. The decrease in general and administrative fees was primary due to the streamlining of our operations to focus on preparation for the Merger, which has since been abandoned. Legal and professional fees were $0.4 million for the six months ended June 30, 2024 compared to $1.7 million for the same period in 2023. The decrease in legal and professional fees was attributed to the lack of non-routine activities that were present in the same period last year, such as the implementation of reverse stock split, and amendments to the memorandum and articles of association. The absence of such non-routine exercises in the current period has resulted in a decrease in legal and professional fees. As of June 30, 2024, cash and restricted cash totaled approximately $0.8 million and total equity was approximately $13.2 million. APTORUM GROUP LIMITED UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS June 30, 2024 and December 31, 2023 (Stated in U.S. Dollars) June 30, 2024 December 31, 2023 ASSETS Current assets: Cash $ 783,085 $ 2,005,351 Accounts receivable 21,800 47,709 Amounts due from related parties 3,595 961 Other receivables and prepayments 725,616 422,071 Total current assets 1,534,096 2,476,092 Property and equipment, net - 1,663,926 Operating lease right-of-use assets - 182,057 Long-term investments 16,098,846 16,098,846 Intangible assets, net - 147,347 Long-term deposits 71,823 71,823 Total Assets $ 17,704,765 $ 20,640,091 LIABILITIES AND EQUITY LIABILITIES Current liabilities: Amounts due to related parties $ 79,180 $ 79,180 Accounts payable and accrued expenses 1,148,235 1,894,341 Operating lease liabilities, current 89,145 125,232 Total current liabilities 1,316,560 2,098,753 Operating lease liabilities, non-current 62,718 99,485 Convertible notes to a related party 3,148,500 3,058,500 Total Liabilities $ 4,527,778 $ 5,256,738 Commitments and contingencies - - EQUITY Class A Ordinary Shares ($0.00001 par value, 9,999,996,000,000 shares authorized, 3,674,164 shares issued and outstanding as of June 30, 2024; 2,937,921 shares issued and outstanding as of December 31, 2023) $ 37 $ 31 Class B Ordinary Shares ($0.00001 par value; 4,000,000 shares authorized, 1,796,934 shares issued and outstanding as of June 30, 2024; 2,243,776 shares issued and outstanding as of December 31, 2023) 18 22 Additional paid-in capital 93,470,186 93,018,528 Accumulated other comprehensive loss (9,762 ) (10,623 ) Accumulated deficit (70,805,518 ) (68,161,722 ) Total equity attributable to the shareholders of Aptorum Group Limited 22,654,961 24,846,236 Non-controlling interests (9,477,974 ) (9,462,883 ) Total equity 13,176,987 15,383,353 Total Liabilities and Equity $ 17,704,765 $ 20,640,091 APTORUM GROUP LIMITED UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS For the six months ended June 30, 2024 and 2023 (Stated in U.S. Dollars) For the six months ended June 30, 2024 2023 Revenue Healthcare services income $ - $ 431,378 Operating expenses Costs of healthcare services - (426,063 ) Research and development expenses (2,038,923 ) (3,212,366 ) General and administrative fees (326,187 ) (1,263,019 ) Legal and professional fees (366,164 ) (1,738,566 ) Other operating expenses (137,233 ) (330,212 ) Total operating expenses (2,868,507 ) (6,970,226 ) Other income (expenses) Loss on investments in marketable securities, net - (9,266 ) Interest expense, net (68,462 ) (93,478 ) Loss on disposal of subsidiaries (4,271 ) - Sundry income 282,353 36,803 Total other income (expenses), net 209,620 (65,941 ) Net loss $ (2,658,887 ) $ (6,604,789 ) Less: net loss attributable to non-controlling interests (15,091 ) (1,117,685 ) Net loss attributable to Aptorum Group Limited $ (2,643,796 ) $ (5,487,104 ) Net loss per share – basic and diluted $ (0.50 ) $ (1.43 ) Weighted-average shares outstanding – basic and diluted 5,339,608 3,849,621 Net loss $ (2,658,887 ) $ (6,604,789 ) Other comprehensive income (loss) Exchange differences on translation of foreign operations 861 (7,485 ) Other comprehensive income (loss) 861 (7,485 ) Comprehensive loss (2,658,026 ) (6,612,274 ) Less: comprehensive loss attributable to non-controlling interests (15,091 ) (1,117,685 ) Comprehensive loss attributable to the shareholders of Aptorum Group Limited (2,642,935 ) (5,494,589 ) About Aptorum Group Aptorum Group Limited (Nasdaq: APM) is a clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The pipeline of Aptorum is also enriched through the co-development of Paths Dx Test, a novel molecular-based rapid pathogen identification and detection diagnostics technology, with Accelerate Technologies Pte Ltd, commercialization arm of the Singapore’s Agency for Science, Technology and Research. For more information about the Company, please visit www.aptorumgroup.com . Disclaimer and Forward-Looking Statements This press release does not constitute an offer to sell or a solicitation of offers to buy any securities of Aptorum Group. This press release includes statements concerning Aptorum Group Limited and its future expectations, plans and prospects that constitute “forward-looking statements” within the meaning of the US Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. In some cases, you can identify forward-looking statements by terms such as “may,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” or “continue,” or the negative of these terms or other similar expressions. Aptorum Group has based these forward-looking statements, which include statements regarding projected timelines for application submissions and trials, largely on its current expectations and projections about future events and trends that it believes may affect its business, financial condition and results of operations. These forward-looking statements speak only as of the date of this press release and are subject to a number of risks, uncertainties and assumptions including, without limitation, risks related to its announced management and organizational changes, the continued service and availability of key personnel, its ability to expand its product assortments by offering additional products for additional consumer segments, development results, the company’s anticipated growth strategies, anticipated trends and challenges in its business, and its expectations regarding, and the stability of, its supply chain, and the risks more fully described in Aptorum Group’s Form 20-F and other filings that Aptorum Group may make with the SEC in the future. As a result, the projections included in such forward-looking statements are subject to change and actual results may differ materially from those described herein. Aptorum Group assumes no obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise. This press release is provided “as is” without any representation or warranty of any kind. View source version on businesswire.com : https://www.businesswire.com/news/home/20241220907803/en/ CONTACT: Aptorum Group Limited Investor Relations Department investor.relations@aptorumgroup.com +44 20 80929299 KEYWORD: NEW YORK UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: ONCOLOGY HEALTH INFECTIOUS DISEASES GENERAL HEALTH CLINICAL TRIALS PHARMACEUTICAL BIOTECHNOLOGY SOURCE: Aptorum Group Limited Copyright Business Wire 2024. PUB: 12/20/2024 04:00 PM/DISC: 12/20/2024 04:00 PM http://www.businesswire.com/news/home/20241220907803/enTitle: 3D Graphics: Rendering HDR Scenes at 1000x Speed with Unparalleled Results
The scammers are getting better and shoppers are increasingly falling for fake online selling sites as it becomes harder to tell what's real and what's not New research by Avast Malware identifies nearly 80,000 counterfeit websites posing as genuine retailers that are targeting New Zealand shoppers of well-known brands like Pandora, Zara, Swatch and H&M. Netsafe's chief online safety officer Sean Lyons says these sites are set up with one purpose - to make people part with their hard-earned money. "The numbers are really quite significant ... we did some research last year and the year before with the Global Anti-Scam Alliance and they've estimated it could be over $2 billion worth of loss to New Zealanders," he says. But according to Jessica Walker, acting head of research and advocacy at Consumer NZ, that figure could be even higher. "There is no central repository gathering this information, so we know what the big financial institutions are being told but that's only based on what's being reported to them, so we think the figure is likely to be staggeringly high." Walker would like to see New Zealand follow Australia and centralise all the work being done in this area. "Having that one stop shop would make such a difference. It's really hard to know where to go and especially when you have a near miss," she says. "People don't have the time to go looking for where to report it, so they don't, which means more and more people are at risk of being harmed." Scammers can strike at any time of the year, but they really up their game during certain holiday periods. "There's definitely a boost around any time when people are shopping more, so Black Friday and Cyber Monday, there is probably an increase in the number of reports we see and then there's probably an increase in the proliferation of these sites themselves," Lyons says. He adds that scammers rely on people being more rushed and eager to make purchases, because they are less likely to take the time to properly check a website's credibility. With the evolution of technology, it is becoming easier for scammers to scam, and harder for customers to see red flags. "[The scammers] are putting a lot of time and effort into creating these scams, but they're putting a lot of time and effort in because they are profitable endeavours," Lyons says. One green flag many Kiwis look for when checking a website's legitimacy is a .nz domain name. But Domain Name Commissioner Barbara Pearse says that is not necessarily a good marker. It does not even guarantee the website is being operated in New Zealand. "To have a .nz domain name, you don't have to be located in New Zealand or be a New Zealand business, they're available globally," she explains. While online scams occur in less than 1 percent of websites in the .nz domain, Pearse says it is still important to check a site's credibility in other ways. Check out how to listen to and follow The Detail here . You can also stay up-to-date by liking us on Facebook or following us on X .Federal appeals court takes step closer to banning TikTok in US: Here's what to know
One of the central themes of the "Chase Green Movement" is the concept of blending physical and virtual workspaces to create a more dynamic and flexible working environment. With the rise of remote work in recent years, organizations have recognized the importance of providing employees with the tools and technologies they need to collaborate effectively, regardless of their physical location.The "Prosecutor's Open Class" series, featuring real-life prosecutors discussing legal concepts and cases in an accessible and engaging manner, has garnered widespread attention for its informative content and impactful storytelling. By addressing topics relevant to minors, such as juvenile delinquency, cyberbullying, and child protection laws, the series aims to raise awareness and promote understanding of the legal system among young viewers. Through these educational videos, minors are equipped with the necessary tools to navigate legal challenges and protect their rights effectively.
King Charles wears once-banned coronation breeches to royal event
Li Gangren, a rising star in the PSG squad, has seen his valuation soar to an impressive 30 million euros. The young talent has been making waves in the football world with his exceptional skills and stellar performances on the field. His impressive goal-scoring record and playmaking abilities have not gone unnoticed, leading to a substantial increase in his market value. Li Gangren's rise in worth reflects his growing importance and potential within the team, as well as his increasing impact on the global football stage.
- Previous:
- Next: winner777 login